Evidence map›Paper›PMID 25981506›Full record

ArticleJACC. Cardiovascular imaging2015

Performance of CMR Methods for Differentiating Acute From Chronic MI.

Martijn W Smulders, Sebastiaan C A M Bekkers, Han W Kim, Lowie M R Van Assche, Michele A Parker, Raymond J Kim

Open access · greenAbstract readComparative StudyMulticenter Study
In one paragraph

Article in JACC. Cardiovascular imaging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2021
    Trial
  2. Article
  3. Article
  4. Cardiac MRI TRadiology advances · 2024
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Martijn W SmuldersDepartment of Cardiology, Maastricht University Medical Center, Maastricht, the Netherlands.
Sebastiaan C A M BekkersDepartment of Cardiology, Maastricht University Medical Center, Maastricht, the Netherlands.
Han W KimDuke Cardiovascular Magnetic Resonance Center, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Lowie M R Van AsscheDuke Cardiovascular Magnetic Resonance Center, Duke University Medical Center, Durham, North Carolina.
Michele A ParkerDuke Cardiovascular Magnetic Resonance Center, Duke University Medical Center, Durham, North Carolina.
Raymond J KimDuke Cardiovascular Magnetic Resonance Center, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Department of Radiology, Duke University Medical Center, Durham, North Carolina. Electronic address: Raymond.kim@duke.edu.
Duke Medical Center · USMaastricht University · NL

Funding

Delayed-Enhancement Cardiac MRI: Prognostic Implications and Improved ImagingR01HL064726 · NHLBI · NORTHWESTERN UNIVERSITY · PI KIM, RAYMOND J · 2001 to 2014
$4.1M
NHLBI NIH HHS 2R01-HL64726NHLBI NIH HHS R01 HL064726
6 · The paper itself

Abstract

objectivesThe purpose of this study was to assess the performance of cardiac magnetic resonance (CMR) methods for discriminating acute from chronic myocardial infarction (MI).

backgroundAlthough T2-weighted CMR is thought to be accurate in differentiating acute from chronic MI, few studies have reported on diagnostic accuracy, and these generally compared extremes in infarct age (e.g., <1 week old vs. more than 6 months old) and did not evaluate other CMR methods that could be informative.

methodsA total of 221 CMR studies were performed at various time points after ST-segment elevation myocardial infarction in 117 consecutive patients without a history of MI or revascularization enrolled prospectively at 2 centers. Imaging markers of acute MI (<1 month) were T2 hyperintensity on double inversion recovery turbo spin echo (DIR-TSE) images, microvascular obstruction (MO) on delayed-enhancement CMR, and focally increased end-diastolic wall thickness (EDWT) on cine-CMR.

resultsThe prevalence of T2-DIR-TSE hyperintensity decreased with infarct age but remained substantial up to 6 months post-MI. In contrast, the prevalence of both MO and increased EDWT dropped sharply after 1 month. T2-DIR-TSE sensitivity, specificity, and accuracy for identifying acute MI were 88%, 66%, and 77% compared with 73%, 97%, and 85%, respectively, for the combination of MO or increased EDWT. On multivariable analysis, persistence of T2-hyperintensity in intermediate-age infarcts (1 to 6 months old) was predicted by larger infarct size, diabetes, and better T2-DIR-TSE image quality score. For infarct size ≥ 10% of the left ventricle, a simple algorithm incorporating all CMR components allowed classification of infarct age into 3 categories (<1 month old, 1 to 6 months old, and ≥ 6 months old) with 80% (95% confidence interval: 73% to 87%) accuracy.

conclusionsT2-DIR-TSE hyperintensity is specific for infarcts <6 months old, whereas MO and increased EDWT are specific for infarcts <1 month old. Incorporating multiple CMR markers of acute MI and their varied longevity leads to a more precise assessment of infarct age.

Indexed as

Acute DiseaseChronic DiseaseDiagnosis, DifferentialFemaleHeart VentriclesHumansMagnetic Resonance Imaging, CineMaleMiddle AgedMyocardial InfarctionReproducibility of ResultsTime Factorsacute MImicrovascular obstructionT2-weighted CMR

Identifiers

PMID25981506
PMCPMC4465991
OpenAlexW2472792310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.